,subject_id,subject_metastatic_disease,subject_dead,subject_age,meddra_disease_preferred_name,subject_sex,subject_ethnicity,os,line_1_therapy,subject_race,ever_smoked,prior_targeted_therapy,prior_surgery,prior_radiation,prior_chemotherapy,prior_treated,prior_car_t,respiratory disease,blood condition,cardiac/heart disease,abnormal blood pressure,allergies,gastrointestinal problems,musculoskeletal condition/problem,neurological problem,endocrine condition/problem,diabetes,vision condition/problem,sinus condition/problem,sleep,previous cancer,dematological conditions,kidney/genitourinary disease,sleep apnea,hearing condition/problem,infectious disease,raynauds,irAE abdominal pain,irAE acute kidney injury,irAE hypophysitis adrenal insufficiency,irAE arthritis,irAE autoimmune haemolytic anaemia,irAE brain oedema,irAE bronchiolitis,irAE carpal tunnel syndrome,irAE cheilitis,irAE chest discomfort,irAE diarrhea colitis,irAE conjunctivitis,irAE constipation,irAE cranial nerve paralysis,irAE dehydration,irAE rash,irAE diabetes mellitus,irAE dry eye,irAE dry mouth,irAE dyspnoea,irAE electrolyte imbalance,irAE gastritis,irAE gout,irAE guillain-barre syndrome,irAE hepatitis,irAE hypersensitivity,irAE thyroid,irAE infusion related reaction,irAE jaundice,irAE keratitis,irAE malaise,irAE motor dysfunction,irAE mucosal inflammation,irAE myocarditis,irAE myositis,irAE neutropenia,irAE pancreatitis,irAE pericarditis,irAE peripheral swelling,irAE pneumonia,irAE pneumonitis,irAE pneumothorax,irAE productive cough,irAE pruritus,irAE pulmonary embolism,irAE pulmonary oedema,irAE systemic inflammatory response syndrome,irAE sinusitis,irAE stomatitis,irAE urinary tract infection,irAE vasculitis,irae_any,irAE Any gastrointestinal disorders,irAE Any renal and urinary disorders,irAE Any endocrine disorders,irAE Any musculoskeletal and connective tissue disorders,irAE Any blood and lymphatic system disorders,irAE Any nervous system disorders,"irAE Any respiratory, thoracic and mediastinal disorders",irAE Any skin and subcutaneous tissue disorders,irAE Any cardiac disorders,irAE Any eye disorders,irAE Any metabolism and nutrition disorders,irAE Any hepatobiliary disorders,irAE Any immune system disorders,irAE Any infusion related reaction,irAE Any general disorders and administration site conditions,irAE Any infections and infestations,irAE Any vascular disorders,days endocrine disorders,days gastrointestinal disorders,days skin and subcutaneous tissue disorders,days musculoskeletal and connective tissue disorders,"days respiratory, thoracic and mediastinal disorders",days cardiac disorders,days immune system disorders,days infusion related reaction_x,days nervous system disorders,days renal and urinary disorders,days hepatobiliary disorders,days general disorders and administration site conditions,days eye disorders,days blood and lymphatic system disorders,days metabolism and nutrition disorders,days infections and infestations,days vascular disorders,days diarrhea colitis,days hypophysitis adrenal insufficiency,days rash,days arthritis,days myositis,days thyroid,days pneumonitis,days gout,days myocarditis,days hypersensitivity,days pruritus,days infusion related reaction_y,days dyspnoea,days motor dysfunction,days diabetes mellitus,days acute kidney injury,days pancreatitis,days hepatitis,days jaundice,days abdominal pain,days systemic inflammatory response syndrome,days gastritis,days chest discomfort,days conjunctivitis,days autoimmune haemolytic anaemia,days pericarditis,days cranial nerve paralysis,days keratitis,days cheilitis,days electrolyte imbalance,days stomatitis,days malaise,days sinusitis,days mucosal inflammation,days constipation,days pulmonary embolism,days pulmonary oedema,days neutropenia,days peripheral swelling,days bronchiolitis,days brain oedema,days carpal tunnel syndrome,days dry eye,days dry mouth,days vasculitis,days pneumonia,days guillain-barre syndrome,days productive cough,days pneumothorax,min_irae_days_first,Severe irAE Acute kidney injury,Severe irAE Hypophysitis Adrenal Insufficiency,Severe irAE Arthritis,Severe irAE Autoimmune haemolytic anaemia,Severe irAE Brain oedema,Severe irAE Diarrhea Colitis,Severe irAE Diabetes mellitus,Severe irAE Electrolyte imbalance,Severe irAE Gastritis,Severe irAE Hepatitis,Severe irAE Thyroid,Severe irAE Motor dysfunction,Severe irAE Mucosal inflammation,Severe irAE Myocarditis,Severe irAE Neutropenia,Severe irAE Pancreatitis,Severe irAE Pericarditis,Severe irAE Pneumonitis,Severe irAE Pruritus,Severe irAE Pulmonary embolism,Severe irAE Rash,Severe irAE Systemic inflammatory response syndrome,irae_severe,Corticosteroid-non systemic_pretreat,Corticosteroid-unclear_pretreat,Corticosteroid-systemic_pretreat,any_corticosteroid_pretreat,systemic_unclear_corticosteroid_pretreat,Steroid_irAE,pneumo_vax_hist,zoster_vax_hist,baseline_influenza_vax,antibiotics_yn,infection_hist_yn,clinical_observation_os_event,clinical_observation_os,Anti-coagulant_pretreat,Anti-pyretic_pretreat,Anti-anxiety_pretreat,Cardiovascular_pretreat,Supplement_pretreat,Anti-depressant_pretreat,Anti-histamine_pretreat,Bronchodilator_pretreat,Anti-emetic_pretreat,Anti-psychotic_pretreat,Muscle Relaxant_pretreat,Anti-convulsant_pretreat,Antibiotics_pretreat,Proton Pump Inhibitor_pretreat,Vitamin_pretreat,Diabetes_pretreat,Thyroid_pretreat,HLD Tx_pretreat,BPH_pretreat,Expectorant_pretreat,Anti-diarrheal_pretreat,Anti-fungal_pretreat,Neuropathy Tx_pretreat,Opioid_pretreat,Laxative_pretreat,Anti-tussive_pretreat,Anti-insomnia_pretreat,Cancer_pretreat,Cholinergic_pretreat,Anti-fungal-non systemic_pretreat,Gas Relief_pretreat,Anesthetic-non systemic_pretreat,Appetite Stimulation_pretreat,Parkinson's_pretreat,Antacid_pretreat,Diuretic_pretreat,Hormone Replacement_pretreat,Anti-glaucoma-non systemic_pretreat,Erectile Dysfunction_pretreat,Osteoporosis_pretreat,Erythropoiesis stimulating agent_pretreat,Analgesic_pretreat,Acid suppression_pretreat,Osteoarthritis_pretreat,Overactive Bladder_pretreat,Gout_pretreat,Macular Degeneration_pretreat,Anti-cholinergic_pretreat,Anti-viral_pretreat,Cannabinoid_pretreat,Anti-glaucoma_pretreat,Growth factor_pretreat,Decongestant-non systemic_pretreat,Anti-histamine-non systemic_pretreat,IBD_pretreat,Protectant_pretreat,Anti-thyroid_pretreat,Stimulant_pretreat,Alzheimer's_pretreat,Cholinergic-non systemic_pretreat,Immunoglobulin_pretreat,Drop-NA_pretreat,Anti-androgen_pretreat,IBS_pretreat,Immunosuppressive_pretreat,Opioid antagonist_pretreat,Decongestant_pretreat,Anti-ulcer_pretreat,Anti-muscarinic_pretreat,Antibiotics-non systemic_pretreat,Mast cell stabilizer-non systemic_pretreat,Anesthetic_pretreat,Supplement-non systemic_pretreat,Hyperkalemia_pretreat,Phosphate Binder_pretreat,ALS_pretreat,Anti-fibrotic_pretreat,Cytoprotectant_pretreat,Barbiturate_pretreat,Migraines_pretreat,Asthma_pretreat,Multiple Sclerosis_pretreat,Psoriasis_pretreat,Huntington's_pretreat,Not on Meds_pretreat,line_1_group,stage,Site,Cancer,Region,irae_n,subject_dead_hospice,subject_os_detail,subject_dead_hospice_censor,subject_os_detail_censor,clinical_observation_censor_os_event,clinical_observation_censor_os,clinical_observation_pfs_event,clinical_observation_pfs,clinical_observation_pfs_reason,probable_pfs_event,probable_pfs,offstudy_reason,Steroid_irAE_NA99,infection_hist_post_abx,post_15_toxevent,smoking_status
0,3-1051,1,,83,Renal cell carcinoma,male,not-hispanic,,pd1-pdl1,white,1.0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1.0,,1.0,1.0,1.0,,,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,pd1-pdl1,iv,RCCA - Little Silver,Renal cell carcinoma (RCC),Northeast,0,,Withdrawn,0,Alive,False,2.467,False,2.467,:clinical-observation.event-reason/withdrew-from-study,False,2.467,Left study per patient preference,99,Abx for Infxn,,former
1,3-1090,1,,54,Renal cell carcinoma,male,not-hispanic,7.933,ctla4+pd1-pdl1,asian,1.0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.0,,,,,,,,,,,,,,,,,,,,,,42.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42.0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0.0,0.0,0.0,0.0,,True,7.933,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,ctla4+pd1-pdl1,iv,New Mexico Oncology & Hematology Consultants - Albuquerque,Renal cell carcinoma (RCC),South,1,1.0,Hospice,1,Hospice,True,7.933,True,6.067,:clinical-observation.event-reason/progressed,True,4.7,Disease progression,0,No Abx Given,0.0,current
2,3-1128,0,,67,Bladder cancer,male,not-hispanic,,pd1-pdl1,white,1.0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,23.0,,5.0,,,,,,,,,,,,,,,,,5.0,,,,,,,,,,,,23.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1.0,1.0,1.0,1.0,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,pd1-pdl1,0,Urology Cancer Center,Urothelial carcinoma (UC),Midwest,2,,Transferred,0,Alive,False,3.467,True,3.467,:clinical-observation.event-reason/censored-unknown,True,3.467,Diagnosed with additional cancer,1,No Abx Given,0.0,former
3,3-1132,0,1.0,79,Hepatocellular carcinoma,female,not-hispanic,3.133,pd1-pdl1,white,0.0,1,1,0,0,0,0,0,0,0,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1.0,1.0,1.0,1.0,0.0,True,3.133,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,pd1-pdl1,iii,Pacific Cancer Care,Hepatocellular carcinoma,West,0,1.0,Dead,1,Dead,True,3.133,True,3.133,:clinical-observation.event-reason/dead,True,3.133,Death,99,Abx Not for Infxn,,never
4,3-1148,1,0.0,68,Malignant melanoma,male,not-hispanic,15.0,ctla4+pd1-pdl1,white,1.0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.0,,,,,,,,,,,,,,,,,,,,,,35.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35.0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.0,1.0,1.0,1.0,1.0,1.0,False,15.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,ctla4+pd1-pdl1,iv,RCCA - Freehold,Melanoma,Northeast,1,0.0,Alive,0,Alive,False,27.3,False,27.3,:clinical-observation.event-reason/censored-study-period-ended,False,27.3,Patient completed all study draws and follow-up window,1,Abx for Infxn,0.0,former
